Reduction in pain intensity · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction in pain intensity · patients with trigeminal neuralgia
1 finding from 1 review
Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia
1 finding from 1 review
Reduction in pain intensity · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reduction in pain intensity · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life assessment 12 weeks after the start of treatment Not measured · patients with trigeminal neuralgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Appetite improvement compared to other drugs Questionnaire of appetite rating · cachexia anorexia syndrome
The intervention showed no clear difference in appetite improvement compared to other drugs Questionnaire of… (low certainty).
1 finding from 1 review
Intervention not reported
Weight improvement compared to other drugs % of patients that improved their weight in kg · cachexia anorexia syndrome
It is very uncertain whether the intervention changes weight improvement compared to other drugs % of patients that… (very low certainty).
1 finding from 1 review
Intervention not reported
Retention to treatment Number of participants who competed treatment · Amphetamine abuse or dependence
The intervention showed no clear difference in retention to treatment Number of participants who competed treatment (low certainty).
1 finding from 1 review
Intervention not reported
Serious drug related adverse events · Children aged less than 5 years
1 finding from 1 review
50% or greater reduction in seizure frequency Number of seizures · people with drug‐resistant focal epilepsy
Gabapentin probably leads to higher reduction in seizure frequency of ≥ 50%: primary analysisNumber of… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects: ataxia Number of participants experiencing ataxia · people with drug‐resistant focal epilepsy
Gabapentin may leads to higher adverse effects: ataxiaNumber of participants experiencing ataxia compared with placebo (low certainty).
1 finding from 1 review
Frequency of adverse effects ‐ dizziness ( · people with drug‐resistant focal epilepsy
Gabapentin probably leads to higher adverse effects: dizzinessNumber of participants experiencing… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effect: fatigue · people with drug‐resistant focal epilepsy
Gabapentin may leads to higher adverse effects: fatigueNumber of participants experiencing fatigue compared with placebo (low certainty).
1 finding from 1 review
Nausea · people with drug‐resistant focal epilepsy
Gabapentin probably leads to lower adverse effects: nauseaNumber of participants experiencing nausea compared with placebo (moderate certainty).
1 finding from 1 review
Somnolence · people with drug‐resistant focal epilepsy
Gabapentin probably leads to higher adverse effects: somnolenceNumber of participants experiencing… compared with placebo (moderate certainty).
1 finding from 1 review
Adverse effects: headache · people with drug‐resistant focal epilepsy
Gabapentin probably leads to lower adverse effects: headacheNumber of participants experiencing headache compared with placebo (moderate certainty).
1 finding from 1 review
Relapse · adults with drug‐sensitive pulmonary tuberculosis
Moxifloxacin‐containing 4‐month ATT regimens probably leads to higher relapse compared with standard 6‐month ATT regimen (moderate certainty).
1 finding from 1 review